Background Analysis of circulating tumour DNA could stratify cancer risk in symptomatic
patients. We aimed to evaluate the performance of a methylation-based multicancer early …

Background International variations in cancer outcomes persist and may be influenced by
differences in the accessibility and organisation of cancer patient pathways. More evidence …

Background Non-specific symptoms are common and often sign of a non-serious disease.
Because of this, patients with non-specific symptoms of cancer (NSSC) present a challenge …

Aims/hypothesis The aim of this study was to describe the long-term trends in cancer
mortality rates in people with type 2 diabetes based on subgroups defined by …

Purpose: Early diagnosis of cancer is critical for improving patient outcomes, but cancers
may be hard to diagnose if patients present with nonspecific signs and symptoms. We have …

Diagnosing cancer earlier can enable timely treatment and optimize outcomes. Worldwide,
national cancer control plans increasingly encompass early diagnosis programs for …

Background Cancer patients often have pre-existing comorbidities, which can influence
timeliness of cancer diagnosis. We examined symptoms, investigations and emergency …

PURPOSE A multi-cancer detection test using a targeted methylation assay and machine
learning classifiers was validated and optimized for screening in prospective, case …

Background In 2011, as the first European country, Denmark introduced the non-organ-
specific cancer patient pathway (CPP) for patients presenting with non-specific symptoms …

Background Blood tests can support the diagnostic process in patients with cancer but how
often they are used is unclear. Aim To explore use of common blood tests before cancer …